BofA raised the firm’s price target on Danaher (DHR) to $270 from $265 and keeps a Buy rating on the shares. The firm says the Q4 earnings report was as expected and mostly consistent with prior messaging. Danaher struck a positive tone, signaling recovery across most end markets, though not yet returning to historical growth. BofA’s read is that Danaher is trying to keep estimates low, not because of any incremental concerns but to leave room for beats and raises as 2026 goes on.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DHR:
- Danaher: Robust Q4 Beat and Credible 2026 Growth Outlook Underpin Buy Rating
- Morning Movers: Starbucks rises after Q1 results and FY26 guidance
- Danaher sees FY26 EPS $8.35-$8.50, consensus $8.42
- Danaher reports Q4 adjusted EPS $2.23, consensus $2.19
- Danaher sees Q1 revenue up low-single digit percent